Detalhe da pesquisa
1.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica
; 106(6): 1559-1568, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32467145
2.
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Br J Haematol
; 181(5): 642-652, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29675955
3.
Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.
Br J Haematol
; 178(4): 583-587, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28439887
4.
Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia.
Br J Haematol
; 174(4): 541-9, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27172403
5.
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Haematologica
; 101(8): 941-50, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27151993
6.
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
J Mol Diagn
; 24(8): 893-900, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35710027
7.
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia.
Leuk Lymphoma
; 63(6): 1512-1514, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35133227
8.
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
Oncotarget
; 7(12): 13886-901, 2016 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-26883104
9.
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.
Leuk Lymphoma
; 60(11): 2838-2840, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31050551